Content deleted Content added
Citation bot (talk | contribs) Add: pmc, pmid, pages, issue, volume, journal, date, title, authors 1-28. | Use this bot. Report bugs. | Suggested by Innerstream | #UCB_webform |
Innerstream (talk | contribs) {{RNA antivirals}} |
||
| Line 63: | Line 63: | ||
==References== |
==References== |
||
{{reflist}} |
{{reflist}} |
||
{{RNA antivirals}} |
|||
[[Category:NS5A inhibitors]] |
[[Category:NS5A inhibitors]] |
||
Revision as of 12:49, 20 April 2024
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| UNII | |
| Chemical and physical data | |
| Formula | C41H50N8O8 |
| Molar mass | 782.899 g·mol−1 |
Coblopasvir is a pharmaceutical drug for the treatment of hepatitis C.[1]
In China, it is approved for use in combination with sofosbuvir for treating naïve or interferon‐experienced adults chronically monoinfected patients with HCV of genotype 1, 2, 3 and 6, with or without compensated cirrhosis.[2]
References
- ^ Rao, Huiying; Song, Guangjun; Li, Guangming; Yang, Yongfeng; Wu, Xiaofeng; Guan, Yujuan; Mao, Qing; Jiang, Xiangjun; Wang, Changyuan; Zhang, Ying; Jia, Jidong; Guo, Xiaolin; Li, Chenghao; Ning, Jing; Qin, Hong; Pan, Hai; Wei, Lai (2020). "Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis". Journal of Viral Hepatitis. 27 (1): 45–51. doi:10.1111/jvh.13208. PMID 31520460.
- ^ Gao, Yanhang; Kong, Fei; Li, Guangming; Li, Cheng; Zheng, Sujun; Lin, Jianmei; Wen, Xiaofeng; Hu, Jinghua; Wang, Xiaozhong; Wu, Xiaofeng; Xing, Huichun; Jia, Jidong; Jia, Zhansheng; Guan, Yujuan; Li, Chenghao; Wu, Guicheng; Gao, Zhiliang; Mou, Zhuangbo; Ning, Qin; Mao, Qing; Yang, Yongfeng; Ning, Jing; Li, Li; Pan, Hai; Zhou, Desheng; Ding, Yanhua; Qin, Hong; Niu, Junqi (2020). "Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial". Liver International. 40 (11): 2685–2693. doi:10.1111/liv.14633. PMC 7702130. PMID 33047868.